Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1141-1150 of 1,778) with videos related to

Pageof 178
Sort By:
Mabs|December 5, 2015
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and developmentJay Tibbitts, David Canter, Ryan Graff, et al.
Mabs|December 15, 2015
Understanding differences between synthetic and natural antibodies can help improve antibody engineeringAnat Burkovitz, Yanay Ofran
Mabs|December 15, 2015
Identification and characterization of a -1 reading frameshift in the heavy chain constant region of an IgG1 recombinant monoclonal antibody produced in CHO cellsZhirui Lian, Qindong Wu, Tongtong Wang
Mabs|December 20, 2015
A method to confer Protein L binding ability to any antibody fragmentZineb Lakhrif, Martine Pugnière, Corinne Henriquet, et al.
Mabs|October 31, 2015
Pharmacokinetic properties of IgG and various Fc fusion proteins in miceFelix Unverdorben, Fabian Richter, Meike Hutt, et al.
Mabs|November 25, 2015
Glycan analysis of therapeutic glycoproteinsLei Zhang, Shen Luo, Baolin Zhang
Mabs|May 25, 2016
Quantitation and pharmacokinetic modeling of therapeutic antibody quality attributes in human studiesYinyin Li, Michael Monine, Yu Huang, et al.
Mabs|July 9, 2016
ABodyBuilder: Automated antibody structure prediction with data-driven accuracy estimationJinwoo Leem, James Dunbar, Guy Georges, et al.
Mabs|July 2, 2016
The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®Bishu Ganguly, Balaji Balasa, Lyubov Efros, et al.
Mabs|July 6, 2016
In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidateLiuxi Chen, Lan Wang, Henry Shion, et al.
Pageof 178

Showing results (1141-1150 of 1,778) with videos related to

Sort By:
Pageof 178
Mabs|December 5, 2015
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and developmentJay Tibbitts, David Canter, Ryan Graff, et al.
Mabs|December 15, 2015
Understanding differences between synthetic and natural antibodies can help improve antibody engineeringAnat Burkovitz, Yanay Ofran
Mabs|December 15, 2015
Identification and characterization of a -1 reading frameshift in the heavy chain constant region of an IgG1 recombinant monoclonal antibody produced in CHO cellsZhirui Lian, Qindong Wu, Tongtong Wang
Mabs|December 20, 2015
A method to confer Protein L binding ability to any antibody fragmentZineb Lakhrif, Martine Pugnière, Corinne Henriquet, et al.
Mabs|October 31, 2015
Pharmacokinetic properties of IgG and various Fc fusion proteins in miceFelix Unverdorben, Fabian Richter, Meike Hutt, et al.
Mabs|November 25, 2015
Glycan analysis of therapeutic glycoproteinsLei Zhang, Shen Luo, Baolin Zhang
Mabs|May 25, 2016
Quantitation and pharmacokinetic modeling of therapeutic antibody quality attributes in human studiesYinyin Li, Michael Monine, Yu Huang, et al.
Mabs|July 9, 2016
ABodyBuilder: Automated antibody structure prediction with data-driven accuracy estimationJinwoo Leem, James Dunbar, Guy Georges, et al.
Mabs|July 2, 2016
The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®Bishu Ganguly, Balaji Balasa, Lyubov Efros, et al.
Mabs|July 6, 2016
In-depth structural characterization of Kadcyla® (ado-trastuzumab emtansine) and its biosimilar candidateLiuxi Chen, Lan Wang, Henry Shion, et al.
Pageof 178